Physician Data Query

Last uploaded: August 28, 2024
Preferred Name

L-lysine
Synonyms

L-lysine monohydrate

L-alpha,epsilon-diaminocaproic acid

lysine monohydrate

Definitions

A nutritional supplement containing the biologically active L-isomer of the essential amino acid lysine, with potential anti-mucositis activity. Upon oral intake, L-lysine promotes healthy tissue function, growth and healing and improves the immune system. L-Lysine promotes calcium uptake, is essential for carnitine production and collagen formation. As collagen is essential for connective tissue maintenance, this agent may also help heal mucosal wounds. This may help decrease and prevent mucositis induced by radiation or chemotherapy. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C95739" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C95739" NCI Thesaurus)

ID

http://purl.bioontology.org/ontology/PDQ/CDR0000680405

altLabel

L-lysine monohydrate

L-alpha,epsilon-diaminocaproic acid

lysine monohydrate

CAS Registry

39665-12-8

cui

C0024337

C3495437

DATE FIRST PUBLISHED

2010-06-17

Date last modified

2017-12-18

definition

A nutritional supplement containing the biologically active L-isomer of the essential amino acid lysine, with potential anti-mucositis activity. Upon oral intake, L-lysine promotes healthy tissue function, growth and healing and improves the immune system. L-Lysine promotes calcium uptake, is essential for carnitine production and collagen formation. As collagen is essential for connective tissue maintenance, this agent may also help heal mucosal wounds. This may help decrease and prevent mucositis induced by radiation or chemotherapy. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C95739" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C95739" NCI Thesaurus)

NCI ID

C95739

notation

CDR0000680405

ORIG STY

Drug/agent

prefLabel

L-lysine

tui

T116

T123

T121

Delete Subject Author Type Created
No notes to display
Create mapping

Delete Mapping To Ontology Source
http://purl.bioontology.org/ontology/MSHFRE/D008239 MSHFRE CUI
http://purl.bioontology.org/ontology/RXNORM/1314248 RXNORM CUI
http://purl.bioontology.org/ontology/SNOMEDCT/418834008 SNOMEDCT CUI
http://purl.bioontology.org/ontology/SCTSPA/75799006 SCTSPA CUI
http://purl.bioontology.org/ontology/SNMI/F-64320 SNMI CUI
http://purl.bioontology.org/ontology/RXNORM/6536 RXNORM CUI
http://purl.bioontology.org/ontology/LNC/LP15716-1 LOINC CUI
http://purl.bioontology.org/ontology/SCTSPA/418834008 SCTSPA CUI
http://purl.bioontology.org/ontology/CSP/0866-5708 CRISP CUI
http://purl.bioontology.org/ontology/MESH/D008239 MESH CUI
http://purl.bioontology.org/ontology/VANDF/4018682 VANDF CUI
http://purl.bioontology.org/ontology/NDDF/000931 NDDF CUI
http://purl.bioontology.org/ontology/LNC/MTHU004103 LOINC CUI
http://purl.bioontology.org/ontology/ATC/B05XB03 ATC CUI
http://purl.bioontology.org/ontology/SNOMEDCT/75799006 SNOMEDCT CUI
http://purl.bioontology.org/ontology/LNC/LP263693-6 LOINC CUI
http://purl.bioontology.org/ontology/NDFRT/N0000146993 NDFRT CUI
http://purl.bioontology.org/ontology/NDFRT/N0000006260 NDFRT CUI
http://purl.bioontology.org/ontology/RCD/X807Q RCD CUI
http://purl.bioontology.org/ontology/RCD/XaDdT RCD CUI
http://purl.bioontology.org/ontology/SCTSPA/734659008 SCTSPA CUI
http://purl.bioontology.org/ontology/SNOMEDCT/734659008 SNOMEDCT CUI
http://purl.obolibrary.org/obo/CHEBI_18019 OBA LOOM
http://purl.obolibrary.org/obo/IMR_0200140 HOIP LOOM
http://purl.obolibrary.org/obo/IMR_0200140 TXPO LOOM
http://purl.jp/bio/10/gmo/GMO_001788 GMO LOOM
http://purl.obolibrary.org/obo/NCIT_C95739 BERO LOOM
http://purl.obolibrary.org/obo/CHEBI_18019 DRON LOOM
http://purl.obolibrary.org/obo/CHEBI_18019 PDRO LOOM
http://purl.obolibrary.org/obo/CHEBI_18019 DINTO LOOM
http://purl.obolibrary.org/obo/CHEBI_18019 DTO LOOM
http://purl.obolibrary.org/obo/CHEBI_18019 GO-PLUS LOOM
http://purl.obolibrary.org/obo/CHEBI_18019 BERO LOOM
http://purl.obolibrary.org/obo/CHEBI_18019 DDSS LOOM
http://purl.obolibrary.org/obo/CHEBI_18019 BIOMODELS LOOM
http://purl.obolibrary.org/obo/CHEBI_18019 CIDO LOOM
http://purl.obolibrary.org/obo/CHEBI_18019 UPHENO LOOM
http://purl.obolibrary.org/obo/CHEBI_18019 CHEBI LOOM
http://purl.obolibrary.org/obo/CHEBI_18019 NIFSTD LOOM
http://purl.obolibrary.org/obo/CHEBI_18019 FYPO LOOM
http://purl.obolibrary.org/obo/CHEBI_18019 ECTO LOOM
http://purl.obolibrary.org/obo/CHEBI_18019 HINO LOOM
http://purl.obolibrary.org/obo/CHEBI_18019 ZP LOOM
http://purl.obolibrary.org/obo/UPa_UPC00047 UPA LOOM
http://www.drugbank.ca/drugs/DB00123 FTC LOOM
http://purl.bioontology.org/ontology/RCD/XaDdT RCD LOOM
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C95739 NCIT LOOM